APA (7th ed.) Citation

L, Y., X, H., G, P., M, T., Y, Z., H, Z., . . . J, C. (2024). Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. Life science alliance, 7(4), . https://doi.org/10.26508/lsa.202302353

Chicago Style (17th ed.) Citation

L, Yin, et al. "Genome-wide CRISPR Screen Reveals the Synthetic Lethality Between BCL2L1 Inhibition and Radiotherapy." Life Science Alliance 7, no. 4 (2024). https://doi.org/10.26508/lsa.202302353.

MLA (9th ed.) Citation

L, Yin, et al. "Genome-wide CRISPR Screen Reveals the Synthetic Lethality Between BCL2L1 Inhibition and Radiotherapy." Life Science Alliance, vol. 7, no. 4, 2024, https://doi.org/10.26508/lsa.202302353.